Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

被引：0
|
作者：
Orly Vardeny
James C. Fang
Akshay S. Desai
Pardeep S. Jhund
Brian Claggett
Muthiah Vaduganathan
Rudolf A. de Boer
Adrian F. Hernandez
Carolyn S. P. Lam
Silvio E. Inzucchi
Felipe A. Martinez
Mikhail N. Kosiborod
David DeMets
Eileen O’Meara
Shelley Zieroth
Josep Comin-Colet
Jaroslaw Drozdz
Chern-En Chiang
Masafumi Kitakaze
Magnus Petersson
Daniel Lindholm
Anna Maria Langkilde
John J. V. McMurray
Scott D. Solomon
机构：
[1] University of Minnesota,Minneapolis VA Center for Care Delivery and Outcomes Research
[2] University of Utah Medical Center,BHF Glasgow Cardiovascular Research Center, School of Cardiovascular and Metabolic Health
[3] Cardiovascular Division, Department of Cardiology, Thoraxcenter
[4] Brigham and Women’s Hospital,Cardiology Department
[5] Harvard Medical School,Department Cardiology
[6] University of Glasgow,General Clinical Research Center and Division of Cardiology
[7] Erasmus Medical Center,undefined
[8] Duke University Medical Center,undefined
[9] National Heart Centre Singapore and Duke–National University of Singapore,undefined
[10] Yale School of Medicine,undefined
[11] Universidad Nacional de Córdoba,undefined
[12] Saint Luke’s Mid America Heart Institute and University of Missouri-Kansas City,undefined
[13] University of Wisconsin,undefined
[14] Montreal Heart Institute and Université de Montréal,undefined
[15] St. Boniface Hospital & University of Manitoba,undefined
[16] Bellvitge University Hospital,undefined
[17] Bio-Heart Bellvitge Institute for Biomedical Research,undefined
[18] University of Barcelona,undefined
[19] Hospitalet de Llobregat,undefined
[20] Medical University Lodz,undefined
[21] Taipei Veterans General Hospital and National Yang Ming Chiao Tung University,undefined
[22] Kinshukai Hanwa Daini Senboku Hospital,undefined
[23] Late-Stage Development,undefined
[24] Cardiovascular,undefined
[25] Renal,undefined
[26] and Metabolism,undefined
[27] BioPharmaceuticals R&D,undefined
[28] AstraZeneca,undefined
来源：
Nature Medicine | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3269 / 3269
相关论文
共 50 条
  • [21] Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial
    Kondo, Toru
    Jering, Karola S.
    Borleffs, C. Jan Willem
    de Boer, Rudolf A.
    Claggett, Brian L.
    Desai, Akshay S.
    Dobreanu, Dan
    Inzucchi, Silvio E.
    Hernandez, Adrian F.
    Janssens, Stefan P.
    Jhund, Pardeep S.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Petersson, Magnus
    Vinh, Pham Nguyen
    Vaduganathan, Muthiah
    Solomon, Scott D.
    McMurray, John J. V.
    CIRCULATION, 2023, 147 (14) : 1067 - 1078
  • [22] Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial
    Kondo, Toru
    Jering, K. S.
    De Boer, R. A.
    Claggett, B. L.
    Desai, A. S.
    Inzucchi, S. I.
    Hernandez, A. F.
    Jhund, P. S.
    Kosiborod, M. N.
    Lam, C. S. P.
    Langkilde, A. M.
    A Martinez, F.
    Vaduganathan, M.
    Solomon, S. D.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 199 - 199
  • [23] In-hospital course of patients with heart failure with Improved ejection fraction in the DELIVER Trial
    Pabon, M. Maria
    Vaduganathan, M.
    Claggett, B.
    De Boer, R.
    Hernandez, A.
    Inzucchi, S.
    Kosiborod, M.
    Lam, C.
    Martinez, F.
    Shah, S.
    Desai, A.
    Jhund, P.
    Mcmurray, J.
    Solomon, S.
    Vardeny, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 362 - 363
  • [24] In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial
    Pabon, Maria A.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Chatur, Safia
    Siqueira, Sara
    Marti-Castellote, Pablo
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    Desai, Akshay S.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Solomon, Scott D.
    Vardeny, Orly
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (12) : 2532 - 2540
  • [25] Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial
    Peikert, Alexander
    Martinez, Felipe A.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Kulac, Ian J.
    Desai, Akshay S.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    DeMets, David
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Shah, Sanjiv J.
    Katova, Tzvetana
    Merkely, Bela
    Vardeny, Orly
    Wilderang, Ulrica
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna-Maria
    McMurray, John J., V
    Solomon, Scott D.
    CIRCULATION-HEART FAILURE, 2022, 15 (10) : E010080
  • [26] Effect of dapagliflozin on outpatient worsening heart failure in patients with mildly reduced or preserved ejection fraction: the DELIVER trial
    Chatur, S.
    Vaduganathan, M.
    Claggett, B. L.
    Desai, A. S.
    Docherty, K. F.
    Jhund, P. S.
    De Boer, R. A.
    Hernandez, A. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Lam, C. S. P.
    Martinez, F. A.
    Shah, S. J.
    Mcmurray, J. V.
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [27] Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
    Ostrominski, John W.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    de Boer, Rudolf A.
    Desai, Akshay S.
    Dobreanu, Dan
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Jhund, Pardeep S.
    Kosiborod, Mikhail
    Lam, Carolyn S. P.
    Langkilde, Anna M.
    Lindholm, Daniel
    Martinez, Felipe A.
    O'Meara, Eileen
    Petersson, Magnus
    Shah, Sanjiv J.
    Thierer, Jorge
    McMurray, John J., V
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1892 - 1901
  • [28] Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction A Prespecified Analysis of DAPA-HF
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Anand, Inder
    Bengtsson, Olof
    Bohm, Michael
    de Boer, Rudolf A.
    DeMets, David L.
    Desai, Akshay S.
    Drozdz, Jaroslaw
    Howlett, Jonathan
    Inzucchi, Silvio E.
    Johanson, Per
    Katova, Tzvetana
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Martinez, Felipe A.
    Merkely, Bela
    Nicolau, Jose C.
    O'Meara, Eileen
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Tereshchenko, Sergey
    Verma, Subodh
    McMurray, John J. V.
    CIRCULATION, 2020, 142 (17) : 1623 - 1632
  • [29] Dapagliflozin in Heart Failure with Preserved Ejection Fraction
    Zweck, Elric
    Westenfeld, Ralf
    Redfors, Bjorn
    Omerovic, Elmir
    Weir, Robin A. P.
    Gabrielli, Domenico
    Oliva, Fabrizio
    Zuccala, Giuseppe
    Solomon, Scott D.
    Vaduganathan, Muthiah
    McMurray, John J. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 286 - 286
  • [30] Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
    Ostrominski, John
    Vaduganathan, M.
    Selvaraj, S.
    Claggett, B.
    Desai, A.
    Jhund, P.
    Kosiborod, M.
    Lam, C.
    Inzucchi, S.
    Martinez, F.
    De Boer, R.
    Hernandez, A.
    Shah, S.
    Mcmurray, J.
    Solomon, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 41 - 41
12345